Sign in

CIK 0001501697

  • Non-accelerated filer
  • Smaller reporting company

X4 Pharmaceuticals, Inc

Sign in to watch
Ticker
XFOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273181608
Phone
+1 857-529-8300
Business address
61 NORTH BEACON STREET, 4TH FLOOR, BOSTON, MA, 02134
Former names
Arsanis, Inc.
Open-market buys, last 90 days
$11,884
in 1 filing
Open-market sales, last 90 days
$33,658
in 1 filing

Net −$21,775. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. KIRSKE DAVID −$34K Chief Financial Officer sold 7% of stake
  2. Craig Adam R +$12K Executive Chairman 1 filing
Date Insider Transaction Shares Price Value Owned after
2021-06-15 Mostafa Adam S. Chief Financial Officer Sale −5,417 $7.84 $42K 123,585
2021-06-15 Ragan Paula President and CEO Grant or award +44,826 451,074
2021-06-02 Bridger Gary Director Grant or award · Stock Option (right to buy) +6,000 $9.50 $57K 6,000
2021-06-02 Aliski William Director Grant or award · Stock Option (right to buy) +6,000 $9.50 $57K 6,000
2021-06-02 WYZGA MICHAEL S Director Grant or award · Stock Option (right to buy) +6,000 $9.50 $57K 6,000
2021-06-02 Stewart Murray Director Grant or award · Stock Option (right to buy) +6,000 $9.50 $57K 6,000
2021-06-02 Lawton Alison Frances Director Grant or award · Stock Option (right to buy) +6,000 $9.50 $57K 6,000
2021-06-02 MCGIRR DAVID W J Director Grant or award · Stock Option (right to buy) +6,000 $9.50 $57K 6,000
2021-06-02 Russo Rene Director Grant or award · Stock Option (right to buy) +6,000 $9.50 $57K 6,000
2021-06-02 Ragan Paula President and CEO Sale −2,400 $9.50 $23K 406,248
2021-06-01 Ragan Paula President and CEO Sale −4,104 $9.41 $39K 408,648
2021-05-03 Ragan Paula President and CEO Sale −2,400 $8.33 $20K 412,752
2021-04-05 Ragan Paula President and CEO Sale −2,400 $9.17 $22K 415,152
2021-03-24 Mostafa Adam S. Chief Financial Officer Grant or award +83,163 112,752
2021-03-24 Taveras Arthur Chief Scientific Officer Grant or award +8,035 8,035
2021-03-24 Cadavid Diego Chief Medical Officer Grant or award +8,035 8,035
2021-03-24 Ragan Paula President and CEO Grant or award +144,629 417,552
2021-03-24 Meisner Derek M General Counsel Grant or award +47,728 64,394
2021-03-02 Ragan Paula President and CEO Sale −2,400 $9.74 $23K 272,923
2021-02-02 Ragan Paula President and CEO Sale −2,400 $7.88 $19K 275,323

Page 10 of 25 · 490 trades